Kevin Bitterman Gemini Therapeutics, Inc. (GMTX) insider trading activity

Kevin Bitterman Transaction History

Date	Transaction	Value	Shares Traded
Aug 22 2025	SELL Open market or private sale	$139,575 $61.03 p/Share	2,287
Aug 14 2025	SELL Open market or private sale	$439,859 $60.99 p/Share	7,212
Aug 13 2025	SELL Open market or private sale	$1,526,426 $61.15 p/Share	24,962
Aug 05 2025	SELL Open market or private sale	$24,075 $60.95 p/Share	395
Jul 30 2025	SELL Open market or private sale	$518,351 $61.04 p/Share	8,492
Jul 24 2025	SELL Open market or private sale	$797,228 $61.17 p/Share	13,033
Jul 23 2025	SELL Open market or private sale	$1,819,161 $60.97 p/Share	29,837
Jul 18 2025	SELL Open market or private sale	$40,590 $61.13 p/Share	664
Jun 17 2024	BUY Open market or private purchase	$8,000,028 $36.0 p/Share	222,223
Mar 05 2024	SELL Open market or private sale	$1,922,539 $73.5 p/Share	26,157
Jan 23 2024	SELL Open market or private sale	$6,934,125 $67.65 p/Share	102,500
Jan 10 2024	SELL Open market or private sale	$1,280,000 $64.0 p/Share	20,000
Dec 14 2023	SELL Open market or private sale	$1,212,596 $59.01 p/Share	20,549
Dec 13 2023	SELL Open market or private sale	$213,767 $60.25 p/Share	3,548
Dec 12 2023	SELL Open market or private sale	$3,272,881 $62.98 p/Share	51,967
Aug 15 2023	SELL Open market or private sale	$3,821,584 $52.4 p/Share	72,931

AKRO

Akero Therapeutics, Inc. Healthcare

Director

South San Francisco, CA

Receive a notification when an Institution or Guru buys or sells GMTX shares.

Notify only if

Value

Get notified when an Gemini Therapeutics, Inc. insider buys or sells GMTX shares.

Notify only if

Operation

Value

Type

Receive news related to Gemini Therapeutics, Inc.